Hepatitis C virus (HCV) causes liver cancer and liver failure. Millions of people in the US have HCV infection, but many don’t know they have it. Why does this matter? There is a cure!

Contact us

Helping Texans Prevent Liver Cancer


Learn more about STOP HCC-HCV

Screen, Treat, Or Prevent Hepatocellular Carcinoma and Hepatitis C Virus     

About Us

Learn about HCV and hepatocellular carcinoma (HCC), the most common type of liver cancer.

About HCV

Resources for physicians and healthcare professionals about screening, managing, and curing HCV

Provider Toolkit

Our Mission

Our program, STOP HCC-HCV, aims to improve the liver health of Texans by screening for HCV, educating the community about HCV and HCC, and transforming healthcare to care for and cure HCV.

News & Updates

HCV treatment reduces liver cancer mortality risks

We know that identifying and treating HCV early with 8-12 weeks of direct acting anti-viral (DAA) medication can prevent the development of hepatocellular carcinoma (HCC), a very dangerous form of liver cancer. But did you know that treatment can also reduce the risk of death in patients who already have a history of HCC? Researchers […]

Read More

World Hepatitis Day

July 28th, World Hepatitis Day, is a time to join together and raise awareness about the the global burden of viral hepatitis.  Visit WorldHepatitisDay to learn how you can get involved.     View the World Hepatitis Alliance’s video on finding the millions of people who have hepatitis and don’t know it:    

Read More

A new model of HCV treatment access

Although the new drugs to treat HCV are very effective (at least 9 out of 10 people can be cured in 8-12 weeks), they are very expensive, especially for people who do not have insurance. Even for patients with insurance, co-pay costs may make treatment unaffordable. Prices are so high that state-funded programs like Medicaid […]

Read More

See all our news